This educational research summary does not replace individual medical or nutrition advice.
Science-news source: ScienceDaily
Eating only 8 hours a day may help control Type 1 diabetes
News publication date: September 10, 2026
News summary
ScienceDaily reported on a new six-month randomized trial in 32 adults with type 1 diabetes and overweight or obesity. Participants were assigned to one of three groups: eating only between noon and 8 p.m. without calorie counting, reducing daily energy intake by about 25%, or making no change to their usual routine. The primary outcome was body weight, and time-restricted eating was not significantly better for weight loss than calorie restriction or the control condition. However, HbA1c fell by about 0.46 percentage points more with the 8-hour eating window than with calorie restriction. The study also found no significant increase in diabetic ketoacidosis, severe hypoglycemia, or severe hyperglycemia. The finding is promising, but it is preliminary and does not support changing eating patterns in type 1 diabetes without medical supervision.
Original research title
Efficacy and Safety of Time-Restricted Eating in Adults With Type 1 Diabetes: A Randomized Controlled Trial
After six months, weight loss with time-restricted eating was not significantly different from calorie restriction or the control condition. HbA1c, however, was 0.46 percentage points lower with the 8-hour eating window than with calorie restriction. Mean glucose and total insulin dose did not differ significantly across groups.
The study does not show that intermittent fasting or unsupervised restriction of eating time is safe or appropriate for everyone with type 1 diabetes. Meal timing may need to be coordinated carefully with insulin dosing, glucose monitoring, and individual clinical circumstances. At this stage, the result is better viewed as a promising direction for larger trials than as a general treatment recommendation.
The sample included only 32 participants and follow-up lasted six months. All participants were adults with type 1 diabetes plus overweight or obesity, so the findings cannot be generalized to everyone with type 1 diabetes. Safety was also assessed under trial monitoring, which is not the same as unsupervised use in everyday life.

Discussion
Comments
Share your view on this research update.
Loading comments…